UPLOAD Filing
Can-Fite BioPharma Ltd.
Date: March 31, 2026 · CIK: 0001536196 · Accession: 0000000000-26-003263
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294760
Letter
Re: Can-Fite BioPharma Ltd. Registration Statement on Form F-3 Filed March 31, 2026 File No. 333-294760 Dear Motti Farbstein:
March 31, 2026
Motti Farbstein Chief Executive Officer and Chief Financial Officer Can-Fite BioPharma Ltd. 26 Ben Gurion Street Ramat Gan 5257346 Israel
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Brandon Sloane, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 31, 2026 Motti Farbstein Chief Executive Officer and Chief Financial Officer Can-Fite BioPharma Ltd. 26 Ben Gurion Street Ramat Gan 5257346 Israel Re: Can-Fite BioPharma Ltd. Registration Statement on Form F-3 Filed March 31, 2026 File No. 333-294760 Dear Motti Farbstein: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brandon Sloane, Esq. </TEXT> </DOCUMENT>